Citadel Advisors
BIOT

Citadel Advisors’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History

Citadel Advisors’s Portfolio BIOT Stock Details BIOT Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
2022
Q3 		$1.44M Sell
2022
Q2 		$1.45M Sell
2022
Q1 		$8.82M Sell
2021
Q4 		$8.82M Sell
2021
Q3 		$8.77M Buy
2021
Q2 		$8.68M Buy
2021
Q1 		$8.69M Buy